Research into the causes of diseases is essential to advance future clinical care. Our Division of Pediatric Endocrinology and Metabolism continues to lead internationally-recognized research in hormonal disorders such as diabetes and growth hormone deficiency. Our site currently hosts active clinical trials.
Our Research
- Improving health outcomes for patients with type 1 diabetes
- Expanding available treatments for pediatric type 2 diabetes
- Perioperative management of diabetes insipidus in brain tumor patients
- Developing best practices for care of children with disorders of sexual development
- Care and management of patients with syndromic pediatric obesity
- Creating systems of care for patients with pediatric metabolic bone diseases
- Evaluating biomarkers for identification of hyperandrogenism in females, specifically polycystic ovarian syndrome and premature adrenarche
- Evaluating the incidence of organic pathology leading to premature adrenarche
- Analysis patterns of host viral response genes in pancreatic islets of type 1 diabetes
- Improving the use of sick day rules to reduce diabetic ketoacidosis admission in patients with diabetes
- Use of growth hormone in patients with chronic kidney disease
Clinical Trials
If you are interested in participating in an endocrinology clinical trial, please view our list of current and active trials.
Recent Publications
- "Diabetic Ketoacidosis Drives COVID-19 Related Hospitalizations in Children with Type 1 Diabetes" Journal of Diabetes
- "Cushing Syndrome as a Failed Cardiac Screen in a Patient with McCune-Albright Syndrome: A Case Report" Journal of Medical Case Reports
- "The Effect of Nutritional Status on Post-Operative Outcomes in Pediatric Otolaryngology-Head and Neck Surgery" International Journal of Pediatric Otorhinolaryngology
- "Brief Assessment of Diabetes-Specific Psychological Flexibility in Racially and Income Diverse Youth with Type 1 Diabetes" Pediatric Diabetes
- "Increased Anxiety Symptoms in Pediatric Type 1 Diabetes during the Acute Phase of COVID-19 Lockdown" Journal of Pediatric Endocrinology & Metabolism
- "Implicit Racial-Ethnic and Insurance-Mediated Bias to Recommending Diabetes Technology: Insights from T1D Exchange Multicenter Pediatric and Adult Diabetes Provider Cohort" Diabetes Technology & Therapeutics
Related Articles
BDNF: A potential target for pain relief
Brain-derived neurotrophic factor plays a critical role in pain sensitivity and may provide novel ap...
Epigenetic Editing Repairs Connections in a Developing Brain Model
Endocrinologist Joan C. Han, MD, and researchers at several universities and the National Institutes...
Racial Disparities: Type 1 Diabetes and COVID-19
Black patients with Type 1 diabetes and COVID-19 were almost four times as likely to present to the ...